A Rare Case of Male Bullous Lupus Erythematosus Complicated with Subsequent Annular Hypopigmentation
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Introduction
Bullous lupus erythematosus (BLE) is a rare subset of systemic lupus erythematosus (SLE) [1] . We experienced a rare case of BLE complicated with annular hypopigmentation. The bullous erythema and subsequent annular hypopigmentation responded to systemic steroid treatment. There have been few studies addressing hypopigmented lesions in lupus erythematosus (LE) . In this study, we would like to introduce a rare case of SLE, and show immunohistochemical and ultrastructural findings of the vitiliginous lesions following erosive erythema.
Case Report
A 57-year-old male patient had noticed itchy erythema on the frontal chest in May 2011, and thereafter experienced disease enlargement and partial crust formation. Since no clinical effect of 10 mg/day of oral prednisolone was observed, he was referred to our hospital on July 7, 2011. In terms of the clinical findings at the first visit, symmetric red papules and centrifugal erythema, surrounded by an annular erosive crust, were distributed on the upper extremities and trunk in line with the seborrheic region. The center of the erythematous lesions in the skin tended to be notably resolved ( fig. 1a) , while the mucosal areas were intact. A fever and symmetrical bullous erythema worsened 1 week after admission ( fig. 1b) . Although his skin disease was initially suspected to be a bullous disease, neither anti-desmoglein 1/3 nor anti-BP 180 antibodies were detected.
Laboratory tests revealed cytopenia (WBC, 10,470/μl; Neu, 72.6%; lymph, 13.0%; mono, 14.0%; eosino, 0.1%; baso, 0.3%; RBC, 3.85 × 10 6 /μl; Hb, 12.7 g/dl; Ht, 38.5%; platelet, 180 × 10 3 /μl), ANA (1/320, homogeneous + speckled pattern), positive anti-Sm antibodies, anti-RNP, anti-cardiolipin antibodies, and low C3 and C4 levels. Metal patch and photo tests were negative, and no internal malignancy was detected by whole-body imaging. A biopsy of the erythematous lesion showed individual apoptotic keratinocytes and liquefaction with partial cleft formation on the epidermis, and lymphocytes predominantly infiltrated in the upper dermis and perivascular area ( fig. 1b) . Pigment incontinentia was notable, along with severe inflammation (fig. 1c) . The direct immunofluorescence findings of the uninvolved lesion were granular deposition of IgG and IgM in the basal membrane.
These laboratory and histological findings led to a final diagnosis of BLE type I. In an immunohistochemical analysis for immunocompetent cells, CD8 + cells, instead of CD4 + cells, and HLA-DR + -activating T cells were found to have densely infiltrated into the epidermis of the erythematous lesion. The number of CD1a + Langerhans cells was decreased. The CD68 + macrophages densely infiltrated into the upper dermis, and there was a slight infiltration of IL-17A + cells and Foxp3 + cells ( fig. 2a-h ).
An increased dose of oral prednisolone was effective not only for spiking fever, cytopenia and hypocomplement level, but also crusted bullae and fused erythema ( fig. 3a) . Instead, annular incomplete hypopigmentation tracing the crusted lesions was noted 1 month later ( fig. 3b ). Our histological observations of the hypopigmented lesion showed a decrease, but not total absence, of melanosomes and melanocytes detected by Masson-Fontana ( fig. 3d-f ) and Melan-A ( fig. 3g-i) staining, respectively. In addition, an ultrastructural analysis of a hypopigmented lesion revealed attenuated melanin production, with the presence of immature melanosomes in the remaining melanocytes, whereas no disturbance of melanin transfer to adjacent keratinocytes was noted ( fig. 3j, k) . The hypopigmented lesions recovered 2 weeks later, without any additional treatment ( fig. 3c ).
Discussion
We experienced a rare case of BLE complicated with annular hypopigmentation. The bullous erythema and subsequent annular hypopigmentation responded to systemic steroid treatment. BLE is a rare variant of SLE, with an incidence of less than 0.2 cases per million per year, and represents only 2-3% of the cases of autoimmune subepidermal bullous dermatoses [2] . Clinically, BLE is characterized by a disseminated vesiculobullous skin rash that may or may not be limited to areas exposed to light. Although it is considered to be an acquired bullous disease caused by anti-type VII collagen antibodies, the same as epidermolysis bullosa acquisita [2] , the bullous lesions in BLE usually remit without scar formation, which is common in cases of epidermolysis bullosa acquisita. Since antibodies such as antidesmoglein 1/3 antibodies and anti-BP 180 antibodies were not detected, the present case of BLE was diagnosed according to the diagnostic criteria [3] .
A histopathological examination revealed subepidermal blisters with neutrophilic microabscesses in the dermal papillae, perivascular inflammatory infiltration composed of lymphomononuclear cells, and in some cases, leukocytoclastic vasculitis [4] . Our case also showed individual apoptotic keratinocytes, liquefaction with a partial cleft on the epidermis and lymphocytes predominantly infiltrating into the upper dermis and perivascular area.
In our case, the annular hypopigmented macules appeared along the edge of the erythematous lesion. Franca and de Souza [5] reviewed the histological features of 12 patients with depigmented or hypopigmented lesions in 220 patients with cutaneous LE, and the most common histological findings were summarized as: cellular infiltration (75%), hyperkeratosis (66.7%), thinning and flattening of the epidermis (58.3%) and lower number of melanocytes compared to normal skin. We observed similar histological findings in our case, including apoptotic keratinocytes, atrophy of the epidermis and superficial lymphocytic infiltration in the dermis and a decreased number of melanocytes.
For a more detailed observation, we carried out the immunohistochemical and ultrastructural analyses for both the erythematous and subsequent hypopigmented lesions. For the immunohistochemical analysis, CD8 + cells (instead of CD4 + cells) and HLA-DR + -activating T cells were found to have densely infiltrated into the epidermis of the erythematous lesion. There was a decrease in the number of CD1a + Langerhans cells. While the CD68 + macrophages densely infiltrated the upper dermis, there was a slight infiltration of IL-17A + cells and Foxp3 + cells. Liquefaction, degeneration and dense infiltration of CD8 + T cells into the epidermis were detected, possibly resulting in hypopigmentation accompanied by LE. Whereas the CD8 + T cells were densely found in the affected lesions, the IL-17A + cells and Foxp3 + regulatory T cells were sparsely present. Moreover, we detected a large number of Th17 cells infiltrating in the depigmented lesions compared to the uninvolved skin in nonsegmental vitiligo patients [6, 7] .
With regard to ultrastructural findings, while melanosome production in melanocytes was attenuated, adjacent keratinocytes took over a significant number of mature melanosomes, indicating that there were decreases in both the melanocyte and melanosome number without impaired melanosome transfer to keratinocytes. Taking into consideration both these immune responses and the lupus condition, we considered the following process to be involved in the pathogenesis of the annular hypopigmentation; Cytotoxic T cells penetrated into the epidermis followed by melanocyte destruction. Thereafter, pigment incontinentia followed by the recruitment of numerous CD68 + melanophages in the upper dermis induced activation of melanin-specific antigen presentation, resulting in positive loop cellular immunity. The CD8 + cytotoxic cell-related immune response was thus induced, and melanocyte were attacked, leading to basal membrane degeneration, which may have played 
Conclusion
We experienced a case of LE associated with annular hypopigmentation. We suppose that a CD8 + cytotoxic cell-related immune response in addition to basal membrane degeneration may play a major role in the development of hypopigmentation associated with LE. Early administration of effective treatment may be important for restoration of the pigmentation.
Although annular hypopigmentation is generally regarded as secondary hypopigmentation after local inflammation, annular hypopigmentation following BLE also occurs in some patients. We believe that using a detailed morphological and hematological analysis in additional patient samples will help to elucidate the exact mechanism(s) underlying the development of hypopigmentation in patients with BLE.
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